What's breaking now, across thousands of outlets.
MILAN — Weight loss with Zealand and Roche’s amylin analog was regarded as disappointing when its Phase 2 obesity trial reported topline data in March. Fuller data unveiled at a conference on Tuesday ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
Merck agreed to pay SciBrunch up to $2.13 billion consisting of $400 million upfront and the remainder in payments tied to achieving milestones across multiple indications.
MILAN — Lilly said Tuesday that its triple agonist, called retatrutide, helped patients with both obesity and type 2 diabetes to lose up to 18.8% of their weight after about a year and a half.
Though not yet approved by any regulatory agency, retatrutide could help improve blood sugar levels and reduce inflammation The ‘Godzilla’ of weight-loss drugs could help improve blood sugar levels…
‘The litigation did not originate with Mr. Ward, and its factual and legal foundation does not depend upon him,’ said the lawyer for dozens of Canadian soldiers and ex-soldiers named in the lawsuit
Penn Badgley infamously swore off sex scenes before the production of “You” Season 4, revealing on a viral episode of his “Podcrushed” podcast in Feb. 2013 that he told showrunner Sera Gamble he was no longer interested in filming intimate scenes on camera. The actor then told Variety later that same month that “it’s important […]
